Talaris Therapeutics
Talaris is a Massachusetts-based biotechnology company that develops and commercializes single-dose cell therapeutics for the treatment of auto-immune diseases.
Business Model:
Revenue: $0
Employees: 51-200
Industries / Tags:
Detailed Talaris Therapeutics Information
Geographic Data
Address: 93 Worcester St.
City: Wellesley
State: MA
Zip: 02481
Country: US
Financial Info
Stage:
series b
Raised Last:
$115M
Raised Total:$215M
Social
Metrics
2,052,862Website Global Rank
9,923Website Monthly Traffic
Twitter Followers
Description
Talaris is a Massachusetts-based biotechnology company that develops and commercializes single-dose cell therapeutics for the treatment of auto-immune diseases.
Contact Phone:
+15023989250
Contact Email:
Talaris Therapeutics went public on 5/6/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/6/2021
IPO Valuation:
$701M
Ticker Symbol:
TALS
IPO Price:
$17/share
Amount Raised:
$150M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
